Amy Moss Trombly - 29 Dec 2023 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Executive Officer
Signature
/s/ Amy Trombly
Issuer symbol
SNOA
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
4
Filing time
29 Dec 2023, 17:26:33 UTC
Previous filing
03 Jul 2023
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +60,000 +53% 173,648 29 Dec 2023 Common Stock 60,000 $0.1800 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control or as provided by Ms. Trombly's employment agreement.
F2 The options were awarded and granted to Ms. Trombly for services performed as part of the Company's annual grant of stock options.